Skip to main content

Table 2 Baseline demographics and clinical characteristics

From: A randomized trial evaluating efficacy of overminus lenses combined with prism in the children with intermittent exotropia

 

Overminus and prism n = 30

Observation n = 30

N

%

N

%

Sex

 Female

13

43.3

15

50.0

 Male

17

56.7

15

50.0

Age

 3 to < 4

3

10.0

4

13.3

 4 to < 5

8

26.7

10

33.3

 5 to < 6

9

30.0

9

30.0

 6 to < 7

10

30.0

7

23.3

 Mean (SD)

4.87 ± 1.01

 

4.63 ± 1.00

 

 Range

3 to 6

 

3 to 6

 

Refractive error (SE, D)

  + 4.00 to <+ 5.00

1

3.3

2

6.7

  + 3.00 to <+ 4.00

2

6.7

4

13.3

  + 2.00 to <+ 3.00

3

10.0

5

16.7

  + 1.00 to <+ 2.00

9

30.0

6

20.0

  + 0.5 to <+ 1.00

15

50.0

13

43.3

 Mean (SD)

1.59 ± 1.05

 

1.64 ± 1.29

 

 Range

+ 0.5 to + 4.5

 

+ 0.5 to + 4.25

 

Exotropia control

 0 to 3

2

6.7

5

16.7

 4 to 6

20

66.7

19

63.3

 7 to 9

8

26.7

6

20.0

 Mean (SD)

5.37 ± 1.65

 

5.60 ± 1.50

 

 Range

2 to 8

 

2 to 8

 

Exodeviation by PACT at distance (PD)

 1 to 9

0

0.0

0

0.0

 10 to 14

0

0.0

0

0.0

 16 to 18

6

20.0

6

20.0

 20 to 25

10

33.3

8

26.7

 30 to 35

10

33.3

13

43.3

 40 to 45

4

13.3

3

10.0

 Mean (SD)

27.80 ± 7.48

 

27.46 ± 7.60

 

 Range

16 to 40

 

16 to 40

 

Exodeviation by PACT at near (PD)

 1 to 9

0

0.0

0

0.0

 10 to 14

1

3.3

1

3.3

 16 to 18

7

23.3

7

23.3

 20 to 25

10

33.3

12

40.0

 30 to 35

9

30.0

9

30.0

 40 to 45

3

10.0

1

3.3

 Mean (SD)

25.13 ± 6.84

 

26.46 ± 8.08

 

 Range

14 to 40

 

14 to 40

 

Preschool Randot near stereoacuity, arcsec (log arcsec)

 40″ (1.6 log arcsec)

3

10.0

4

13.3

 60 ~ 80″ (1.78 log arcsec)

7

23.3

9

30.0

 100 ~ 140″ (2.0 log arcsec)

6

20.0

5

16.7

 200″ (2.3 log arcsec)

5

16.7

4

13.3

 400″ (2.6 log arcsec)

5

16.7

3

10.0

 800″ (2.9 log arcsec)

3

10.0

4

13.3

 Nil (3.1 log arcsec)

1

3.3

1

3.3

 Mean (SD) (log arcsec)

2.14 ± 0.46

 

2.19 ± 0.44

 

 Range (log arcsec)

1.6 to 3.1

 

1.6 to 3.1